HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vacuum-assisted closure therapy increases local interleukin-8 and vascular endothelial growth factor levels in traumatic wounds.

AbstractBACKGROUND:
Clinical observations are suggesting accelerated granulation tissue formation in traumatic wounds treated with vacuum-assisted closure (VAC). Aim of this study was to determine the impact of VAC therapy versus alternative Epigard application on local inflammation and neovascularization in traumatic soft tissue wounds.
METHODS:
Thirty-two patients with traumatic wounds requiring temporary coverage (VAC n = 16; Epigard n = 16) were included. At each change of dressing, samples of wound fluid and serum were collected (n = 80). The cytokines interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), and fibroblast growth factor-2 were measured by ELISA. Wound biopsies were examined histologically for inflammatory cells and degree of neovascularization present.
RESULTS:
All cytokines were found to be elevated in wound fluids during both VAC and Epigard treatment, whereas serum concentrations were negligible or not detectable. In wound fluids, significantly higher IL-8 (p < 0.001) and VEGF (p < 0.05) levels were detected during VAC therapy. Furthermore, histologic examination revealed increased neovascularization (p < 0.05) illustrated by CD31 and von Willebrand factor immunohistochemistry in wound biopsies of VAC treatment. In addition, there was an accumulation of neutrophils as well as an augmented expression of VEGF (p < 0.005) in VAC wound biopsies.
CONCLUSION:
This study suggests that VAC therapy of traumatic wounds leads to increased local IL-8 and VEGF concentrations, which may trigger accumulation of neutrophils and angiogenesis and thus, accelerate neovascularization.
AuthorsLudwig Labler, Mario Rancan, Ladislav Mica, Luc Härter, Daniela Mihic-Probst, Marius Keel
JournalThe Journal of trauma (J Trauma) Vol. 66 Issue 3 Pg. 749-57 (Mar 2009) ISSN: 1529-8809 [Electronic] United States
PMID19276749 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Fluorocarbon Polymers
  • Interleukin-6
  • Interleukin-8
  • Platelet Endothelial Cell Adhesion Molecule-1
  • Vascular Endothelial Growth Factor A
  • von Willebrand Factor
  • Fibroblast Growth Factor 2
  • polytetrafluoroethane
Topics
  • Adult
  • Amputation, Traumatic (immunology, pathology, therapy)
  • Arm Injuries (immunology, pathology, therapy)
  • Biopsy
  • Female
  • Fibroblast Growth Factor 2 (blood)
  • Fluorocarbon Polymers
  • Fractures, Open (immunology, pathology, therapy)
  • Humans
  • Injury Severity Score
  • Interleukin-6 (blood)
  • Interleukin-8 (blood)
  • Leg Injuries (immunology, pathology, therapy)
  • Leukocyte Count
  • Male
  • Middle Aged
  • Negative-Pressure Wound Therapy
  • Neovascularization, Pathologic (immunology, pathology)
  • Neutrophils (immunology)
  • Platelet Endothelial Cell Adhesion Molecule-1 (blood)
  • Skin Transplantation
  • Soft Tissue Injuries (immunology, pathology, therapy)
  • Surgical Flaps
  • Vascular Endothelial Growth Factor A (blood)
  • Wound Healing (immunology)
  • Wounds and Injuries (immunology, pathology, therapy)
  • von Willebrand Factor (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: